Company

Cimeio Therapeutics

Biotechnology Research Cambridge, Ma, United States 19 employees

Employees: 19
Contacts: 3
Emails: 3
Phones: 1

www.cimeio.com LinkedIn Crunchbase

Cimeio Therapeutics Overview

Headquarters: Cambridge, Ma, United States
Website: www.cimeio.com
Industry: Biotechnology Research
Employees: 19
Founded: 2020
Funding: 50.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Cimeio Therapeutics

Cimeio Therapeutics is an applied gene editing, cellular, and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs for patients with serious and life-threatening diseases. Cimeio’s proprietary technology platform is based on the discovery of protein variants, which when edited into cells allow them to maintain full function while resisting paired immunotherapy depletion. This technology has significant therapeutic potential, which Cimeio is using to develop curative treatments for patients with genetic diseases, hematologic malignancies, and severe autoimmune disorders.

Cimeio Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Cimeio Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Daniela Hoegger	External Consultant	Zürich Metropolitan Area, Switzerland	Email
Julie Brault	Senior Scientist Analytical Development		View
Daniel Stark		Basel, Switzerland	Email
Stefanie Urlinger	Cso Bei Cimeio Therapeutics	Greater Munich Metropolitan Area, Germany	Email Phone